Warning: Constant WP_CACHE already defined in /home/bicollgroup/public_html/wp-config.php on line 8
Publications - Bicoll GmbH

Publications

Declining Biodiversity – A Threat to Future Pharmaceutical Development

China is home to Artemisia annua, a herb that has been used in traditional medicine for almost 2,000 years. Its main active compound, artemisinin, has been found to be very effective as treatment against resistant malaria. Since 2001, the World Health Organisation (WHO) has recommended to switch to an
artemisinin-based combination therapy in countries where conventional malaria drugs have failed. Much like this example, scientists in the pharmaceutical development field are also often inspired by natural products in their research programs. They hope to develop tomorrow’s medical break-throughs by discovering Nature’s secrets.

Read more

Bicoll – Positive Bilanz

Die Bicoll GmbH hat laut eigenen Angaben das abgelaufene Geschäftsjahr mit einem Gewinn abgeschlossen. Bereits drei Jahre nach der Gründung weise das Unternehmen nach Abzug von Steuern eine positive Bilanz auf. Bicolls Hauptprodukte sind optimierte Substanz-Bibliotheken für
die Wirkstoffidentifizierung in der biopharmazeutischen Industrie.

Read more

Bicoll in profit after three years

Bicoll in profit after three years Sino-German biotech Bicoll (Shanghai/Munich) has generated
its maiden after-tax profit in only its third year of operations. The firm, which specialises in high-tech natural product chemistry, has five strategic customers for its optimised small molecule libraries (known as Bilobac N) for drug discovery. Using its technology, including prediction toolbox Bipreselect,
Bicoll tests and develops its libraries for fees and milestone payments as well as working on in-house projects (BVV Vol 17, No 17, p13). This financial milestone places Bicoll “in a stable position from where we can target our second phase of growth to release the full potential of the company”, commented managing director Dr Kai Lamottke.

Read more

Positives Geschäftsergebnis für Bicoll nach nur drei Geschäftsjahren

Die Bicoll GmbH, München gab heute ein positives Geschäftsergebnis für das letzte abgeschlossene Geschäftsjahr bekannt. Bereits drei Jahre nach der Gründung des ersten deutsch-chinesischen Biotechnologie-Unternehmens (München, Shanghai) weist das Unternehmen nach Abzug aller Steuern ein positives Ergebnis auf. Bicoll spezialisiert …

Read more

Bicoll breaks even and looks to new projects

The private Sino-German bioventure, Bicoll, has moved to its first annual after-tax profit after three years of operations, helped by several agreements with pharmaceutical industry and research institution customers. The group provides a range of combinatorial chemistry, structural biology/chemistry, screening …

Read more

Case Study Bicoll

The Bicoll case concerns the first Sino-German biotech company Bicoll group, located in Munich, Germany and Shanghai, China. Below, an introduction of the company, kindly provided by the Bicoll Group, is followed by an extensive interview between the author of …

Read more

Pionierarbeit – auch in der Mitarbeiterführung

Im Jahr 2001 gründete die Münchener Bicoll GmbH eine Tochtergesellschaft in Shanghai. Da es sich um das erste deutsch-chinesische Unternehmen im Bereich Biotechnologie handelte, musste bei der Führung und Steuerung der Tochtergesellschaft Pionierarbeit geleistet werden.

Read more